NPI registry status
Active
2026 NPPES data Anatomic Pathology Physician NPI 1124254586 MD
Verify on CMS → Cheri Blacksten, MD
Anatomic Pathology Physician in Albuquerque, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,628 in Anatomic Pathology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 164 beneficiaries · Anatomic Pathology Physician avg: 445
Generic prescribing
81%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$802.42
41 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Cheri Blacksten, MD filed 2,815 Medicare Part D claims in 2024 as an Anatomic Pathology Physician in Albuquerque, New Mexico, prescribing 81% generic.
- 3K
- Part D claims, 2024
- 81%
- generic prescribing
- $802.42
- industry payments (Sunshine Act)
- ≥88th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Cheri Blacksten, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1124254586), first enumerated 05/29/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,815 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$802.42 in reported industry payments (41 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1124254586 · Anatomic Pathology Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1124254586
- ENUM-MID 2009
- TAX-NARROW 2,628
- RX-MID 2,815
- BOOK-THIN 10 in New Mexico
- PHOTO-ENUM Victor Collazo Rodri… · 2009
Cheri Blacksten, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,815 ≥ 88th percentile 88% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Cheri Blacksten, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Cheri Blacksten, MD?
Quality data not reportedPrimary specialty
Anatomic Pathology Physician
Medicare Part D claims
2,815 6× vs specialty avg
Specialty distribution in New Mexico
How Anatomic Pathology Physician compares to other specialties among New Mexico providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Anatomic Pathology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1124254586 |
|---|---|
| Specialty | Anatomic Pathology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 05/29/2009 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Cheri Blacksten, MD. Source: openpaymentsdata.cms.gov.
Total received
$802
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Cheri Blacksten, MD - brand share 18.0%
Anatomic Pathology Physician average
18% brand-name claims vs 81% generic, on 2,815 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,815
Total Claims
$401K
Total Drug Cost
164
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,943.067
- Total Day Supply
- 167,725
- Brand vs Generic
- 18% brand / 81% generic
- Brand Drug Cost
- $348K
- Generic Drug Cost
- $51K
- Opioid Claims
- 72 (2.6% rate)
- Antibiotic Claims
- 172
Patient Demographics
- Average Patient Age
- 73.0 years
- Avg HCC Risk Score
- 1.08
- Gender Split
- 68% female / 32% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Cheri Blacksten, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Atorvastatin Calcium
Atorvastatin Calcium
123 claims
- Lisinopril
Lisinopril
112 claims
- Levothyroxine Sodium
Levothyroxine Sodium
111 claims
- Gabapentin
Gabapentin
62 claims
- Losartan Potassium
Losartan Potassium
60 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
58 claims
- Farxiga
Farxiga
52 claims
- Famotidine 47
Famotidine
47 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 123 |
| Lisinopril | 112 |
| Levothyroxine Sodium | 111 |
| Gabapentin | 62 |
| Losartan Potassium | 60 |
| Rosuvastatin Calcium | 58 |
| Farxiga Dapagliflozin Propanediol | 52 |
| Famotidine | 47 |
| Amlodipine Besylate | 43 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 43 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Anatomic Pathology Physician Overview
How Cheri Blacksten, MD fits within the Anatomic Pathology Physician landscape nationally.
2,628
Anatomic Pathology Physician Providers in US
54
States with Anatomic Pathology Physician
445
Avg Claims per Provider
Cheri Blacksten, MD's 2,815 claims are above the specialty average of 445.
Nationwide Anatomic Pathology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Blacksten, both outside New Mexico so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Anatomic Pathology Physician Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Blacksten.
One of 10 Anatomic Pathology Physician providers enrolled in New Mexico, 5 are shown here.
Dr. Elaine Bearer
M.D.
Albuquerque, NM
Dr. Claire Detweiler
M.D.
Albuquerque, NM
Dr. Jack Garland
M.D.
Taos, NM
Dr. Patricia Konrad
MD
Taos, NM
Dr. Henry McNett
M.D.
Albuquerque, NM
Compare Anatomic Pathology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Cheri Blacksten, MD's specialty? ▼
Cheri Blacksten, MD specializes in Anatomic Pathology Physician and practices in Albuquerque, New Mexico. Credentials: MD.
How much does Cheri Blacksten, MD prescribe under Medicare Part D? ▼
In 2024, Cheri Blacksten, MD wrote 2,815 Medicare Part D claims totaling $401K in drug costs for 164 beneficiaries.
Where is Cheri Blacksten, MD located? ▼
Cheri Blacksten, MD is located at 8202 LOUISIANA BLVD NE, Albuquerque, NM, 87113. Phone: (505) 554-2409.
What is Cheri Blacksten, MD's NPI number? ▼
Cheri Blacksten, MD's National Provider Identifier (NPI) is 1124254586, issued on 05/29/2009.
Does Cheri Blacksten, MD prescribe more brand-name or generic drugs? ▼
Cheri Blacksten, MD's prescribing is 18% brand-name and 81% generic drugs by claim count, with $348K in brand drug costs.
Does Cheri Blacksten, MD prescribe opioids? ▼
Yes, Cheri Blacksten, MD had 72 opioid claims in 2024 with an opioid prescribing rate of 2.6%.
How many Anatomic Pathology Physician providers are there in the US? ▼
There are 2,628 Anatomic Pathology Physician providers across 54 states in the US. The average Anatomic Pathology Physician provider writes 445 Medicare Part D claims per year.
What drugs does Cheri Blacksten, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Cheri Blacksten, MD's most frequently prescribed drugs include Atorvastatin Calcium, Lisinopril, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Cheri Blacksten, MD accept Medicare? ▼
Cheri Blacksten, MD appears in CMS Medicare data with 2,815 Part D claims and 164 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Cheri Blacksten, MD's credentials? ▼
Cheri Blacksten, MD's NPI is 1124254586 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.